MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -19.26M | -12.87M | -3.27M | 1.34M | 3.34M |
| Total Depreciation and Amortization | 283.00K | 331.00K | 344.00K | 366.00K | 406.00K |
| Total Amortization of Deferred Charges | 4.91M | 2.30M | -- | -- | -- |
| Total Other Non-Cash Items | 997.00K | 422.00K | 7.00K | -918.00K | -1.24M |
| Change in Net Operating Assets | 1.35M | 1.78M | -2.99M | -3.75M | -3.43M |
| Cash from Operations | -11.72M | -8.04M | -5.90M | -2.96M | -931.00K |
| Capital Expenditure | 2.00K | -2.00K | -3.00K | -7.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 2.00K | 211.00K | 211.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.00K | -2.00K | -1.00K | 204.00K | 203.00K |
| Total Debt Issued | 60.02M | 58.84M | 55.49M | 55.09M | 51.69M |
| Total Debt Repaid | -47.51M | -50.73M | -50.29M | -52.54M | -50.99M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -848.00K | -848.00K | -- | -- | -- |
| Cash from Financing | 11.66M | 7.26M | 5.20M | 2.56M | 702.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.00K | -780.00K | -701.00K | -197.00K | -26.00K |
